A phase I trial of intravenous interleukin-6 in patients with advanced cancer.
Weber J, Gunn H, Yang J, Parkinson D, Topalian S, Schwartzentruber D, Ettinghausen S, Levitt D, Rosenberg SA.
Weber J, et al.
J Immunother Emphasis Tumor Immunol. 1994 May;15(4):292-302. doi: 10.1097/00002371-199405000-00008.
J Immunother Emphasis Tumor Immunol. 1994.
PMID: 7520334
Clinical Trial.